March 2025, Volume :38 Number 2 , page E12 - E17 [Free]
Join NursingCenter to get uninterrupted access to this Article
HOMA-IR is a novel serum index associated with PrI history in persons with chronic SCI. Future longitudinal study is warranted to examine the role of insulin resistance in increasing PrI risk for the SCI population.
Join NursingCenter on Social Media to find out the latest news and special offers
© 2025 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v10.04.00